Joel M Montgomery
Overview
Explore the profile of Joel M Montgomery including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
198
Citations
5087
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ortega E, Simonson S, Shedroff E, Whitmer S, Whitesell A, Choi M, et al.
Emerg Infect Dis
. 2025 Feb;
31(2):401-403.
PMID: 39983678
During 2020-2023, we sequenced Bayou virus from 2 patients in Louisiana, USA, with hantavirus cardiopulmonary syndrome. Direct virus sequencing demonstrated an inferred evolutionary relationship to previous cases. Our findings demonstrate...
2.
Sayyad L, Smith K, Sadigh K, Cossaboom C, Choi M, Whitmer S, et al.
Open Forum Infect Dis
. 2025 Feb;
12(2):ofaf002.
PMID: 39896983
Background: Lymphocytic choriomeningitis virus (LCMV) infection in immunocompromised hosts can result in disseminated disease, meningoencephalitis, and death. Published cases in transplant recipients have been traced to transmission from infected donors....
3.
Bakamutumaho B, Juma J, Clancey E, Nyakarahuka L, Situma S, Odinoh R, et al.
medRxiv
. 2025 Jan;
PMID: 39867400
Introduction: Recent Rift Valley fever (RVF) epidemiology in eastern Africa region is characterized by widening geographic range and increasing frequency of small disease clusters. Here we conducted studies in southwestern...
4.
Welch S, Spengler J, Westover J, Bailey K, Davies K, Aida-Ficken V, et al.
Sci Transl Med
. 2024 Nov;
16(774):eado7034.
PMID: 39565871
Development of broad-spectrum antiviral therapies is critical for outbreak and pandemic preparedness against emerging and reemerging viruses. Viruses inducing hemorrhagic fevers cause high morbidity and mortality in humans and are...
5.
Sorvillo T, Ritter J, Welch S, Coleman-McCray J, Davies K, Hayes H, et al.
Emerg Microbes Infect
. 2024 Nov;
13(1):2427782.
PMID: 39513496
Crimean-Congo haemorrhagic fever virus (CCHFV) causes human disease ranging from subclinical to a fatal haemorrhagic syndrome. Determinants of CCHF pathogenesis are largely unknown and animal models that recapitulate human disease...
6.
Balinandi S, Mulei S, Whitmer S, Nyakarahuka L, Cossaboom C, Shedroff E, et al.
PLoS Negl Trop Dis
. 2024 Oct;
18(10):e0012595.
PMID: 39413127
Background: In September 2022, Uganda experienced an outbreak of Sudan virus disease (SVD), mainly in central Uganda. As a result of enhanced surveillance activities for Ebola disease, samples from several...
7.
Shedroff E, Whitmer S, Mobley M, Morales-Betoulle M, Martin M, Brignone J, et al.
Microbiol Resour Announc
. 2024 Oct;
13(11):e0044124.
PMID: 39400135
New World orthohantaviruses are rodent-borne tri-segmented viruses that cause hantavirus cardiopulmonary syndrome in humans in the Americas. Molecular diagnostics for orthohantaviruses can be improved with more sequence data. Reported here...
8.
Kainulainen M, Harmon J, Karaaslan E, Kyondo J, Whitesell A, Twongyeirwe S, et al.
J Med Virol
. 2024 Oct;
96(10):e29946.
PMID: 39370872
Ebola disease (EBOD) in humans is a severe disease caused by at least four related viruses in the genus Orthoebolavirus, most often by the eponymous Ebola virus. Due to human-to-human...
9.
Lo M, Jain S, Davies K, Sorvillo T, Welch S, Coleman-McCray J, et al.
Antiviral Res
. 2024 Sep;
231:106013.
PMID: 39326503
Nipah virus (NiV) causes near-annual outbreaks of fatal encephalitis and respiratory disease in South Asia with a high mortality rate (∼70%). Since there are no approved therapeutics for NiV disease...
10.
Mukadi-Bamuleka D, Edidi-Atani F, Morales-Betoulle M, Legand A, Nkuba-Ndaye A, Bulabula-Penge J, et al.
Lancet Microbe
. 2024 Sep;
5(10):100905.
PMID: 39236738
Background: During the 2018-20 Ebola virus disease outbreak in the Democratic Republic of the Congo, thousands of patients received unprecedented vaccination, monoclonal antibody (mAb) therapy, or both, leading to a...